K. Tyndall

Maintenance Immunosuppressive Drug Therapy and Potential Major Complications

D. Cooper, K. Tyndall, 1996 .

Background Correction in Multicomponent Spectroscopic Analysis Using Target Transformation Factor Analysis

Paul J. Gemperline, P. Gemperline, Kimberly Tyndall, 1987 .

Patient-Customized Oligonucleotide Therapy for a Rare Genetic Disease.

Jinkuk Kim, Annapurna Poduri, P Ellen Grant, 2019, The New England journal of medicine.

The Introduction of Qualitative Rapid Microbiological Methods for Drug-Product Testing

P. Cooney, P. Newby, K. Tyndall, 2004 .

Patient-customized oligonucleotide therapy for a rare genetic disease

S. Waisbren, P. Grant, Jinkuk Kim, 2020 .